TP53 and neoplasm: The TP53 gene is an oncogene that is mutated in more than 50% of all malignant tumors, dysfunction of this gene seriously affects the cell cycle and induces tumor development, and the high level of TP53 in glioma was found to significantly affect patient survival (34).